-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Sell on Hims & Hers Health, Lowers Price Target to $13.25

Benzinga·02/24/2026 17:41:39
Listen to the news
Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Sell and lowers the price target from $16.5 to $13.25.